Trial Details
Not RecruitingBasic Information
| Clinical ID | c5433 |
|---|---|
| Identifier | ACTRN12622001434785 |
| Trial Title | Maintaining Remission of Ulcerative Colitis with Faecal Microbiota Transplantation: the MR-UC-FMT Trial |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Ulcerative Colitis;Inflammatory Bowel Disease; Ulcerative Colitis Inflammatory Bowel Disease;Oral and Gastrointestinal - Inflammatory bowel disease;Inflammatory and Immune System - Autoimmune diseases |
| Interventions | All patients will receive Prednisolone 50mg oral tablet daily for Week 1, Prednisolone 37.5mg oral tablet daily for Week 2, Prednisolone 25mg oral tablet daily for Week 3 and 4, Prednisolone 20mg oral tablet daily for week 5, Prednisolone 15mg oral tablet |
Participant Information
| Sponsor | Central Adelaide Local Health Network |
|---|---|
| City | NULL |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |